Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: Results of a multicenter phase II study1 1On behalf of Gruppo Oncologico Italia Meridionale.-Reference-Cited by-同舟云学术

Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: Results of a multicenter phase II study1 1On behalf of Gruppo Oncologico Italia Meridionale.

Published:2004-04 Issue: Volume:31 Page:13-19
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Brandi Mario,Vici Patrizia,Lopez Massimo,Valerio Maria Rosaria,Giotta F,Gebbia Nicola,Schittulli Francesco,Colucci Giuseppe

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference28 articles.

1. Treatment of breast cancer;Hortobagyi;N Engl J Med,1998

2. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer;Greenberg;J Clin Oncol,1996

3. Treatment of relapse of breast cancer after adjuvant systemic therapy-Review and guidelines for future research;Rubens;Eur J Cancer,1994

4. Current status of salvage chemotherapy for refractory advanced breast cancer;Vogel;Oncology,1996

5. Treatment of patients resistant to anthracycline therapy;Ravdin;Anticancer Drugs,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pooled Analysis of Gemcitabine Plus Docetaxel Versus Capecitabine Plus Docetaxel in Metastatic Breast Cancer;The Oncologist;2014-04-04

2. Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes;International Journal of Clinical Oncology;2012-02-17

3. Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group;Journal of Clinical Oncology;2011-12-20

4. Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials;Cancer Chemotherapy and Pharmacology;2011-05-06

5. Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial;Cancer Chemotherapy and Pharmacology;2011-02-16